Corneal Persistent Epithelial Defect clinical trials at UCLA

1 research study open to eligible people

KPI-012 Ophthalmic Solution in Participants With PCED
open to eligible people ages 18 years and up
The primary objective of the study is to investigate the safety and efficacy of KPI-012 compared to vehicle in participants who have a documented clinical diagnosis of PCED.
Los Angeles, California and other locations

Last updated: September 4, 2024